|
|
|
28.01.26 - 15:18
|
Renewable Ventures Nordic AB completes reverse acquisition of Xer Tech AB (Cision)
|
|
|
Renewable Ventures Nordic AB (publ) (under name change to Xer Tech Holding AB) ("RVN" or the "Company") today announces that the reverse acquisition of Xer Tech AB (“Xer Tech”), pursuant to the agreement entered into and announced on November 11, 2025, has been completed (the “Transaction”). In connection with the Transaction, the Company has also completed a directed share issue of approximately SEK 80 million (the “Directed Issue”), as previously communicated. As a result of the completion of the Transaction, the Company will change its name to Xer Tech Holding AB and a new board of...
|
|
|
|
|
|
|
|
|
28.01.26 - 14:12
|
#26-11 Tangiamo Touch Technology AB has changed its name to 36 Group AB (Cision)
|
|
|
Tangiamo Touch Technology AB, whose shares are listed on NGM, has changed its name to 36 Group AB. New Listing name, new Exchange symbol and new FISN-code will be entered in the trading system from January 30, 2026. The ISIN-code and the Instrument-ID will remain unchanged.
Information regarding the affected instruments:
New Listing name: 36 Group
New Exchange symbol: 36GRP
ISIN-code: SE0023468194
CFI-code: ESVUFR
New FISN-code: 36GROUP/SH
Instrument-ID: GG6D
Market-ID: NSME
Segment-ID: NSSE
For more information about this Market Notice, please...
|
|
|
|
|
28.01.26 - 13:30
|
Smoltek Hydrogen admitted into Swedish-German Cleantech Platform 2026 – strengthens position in Europe′s leading hydrogen market (Cision)
|
|
|
This press release is an English version of the previously published Swedish version, which has interpretive precedence.
Smoltek Nanotech Holding AB (publ) (“Smoltek” or the “Company”) announces that its subsidiary Smoltek Hydrogen has been accepted as one of nine Swedish cleantech companies to the Swedish-German Cleantech Platform 2026, which is run by the Swedish Energy Agency and the German-Swedish Chamber of Commerce. The program provides Smoltek Hydrogen with the opportunity to expand into Germany's rapidly growing hydrogen market, as well as to accelerate the commercial development...
|
|
|
28.01.26 - 13:06
|
Cereno Scientific to Present CS014 Data and Participate in Panel at Scientific Conference PVRI 2026 Dublin (Cision)
|
|
|
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the company will attend and participate at the PVRI 2026 Annual Congress in Dublin, Ireland, on January 28 – February 1, 2026. Data relating to CS014's preclinical studies and Phase I trial will be presented by Tatiane Dall'Agnol, Medical Director, and Chief Scientific Officer Björn Dahlöf will facilitate an industry roundtable discussion.
“CS014 continues to strengthen the value of our HDAC...
|
|
|
28.01.26 - 13:06
|
Media News: Verve Group SE (EQS)
|
|
|
Verve Group publishes LinkedIn case study validating demand-side growth strategy in privacy-first mobile advertising...
|
|
|
28.01.26 - 13:01
|
#26-10 The observation status for Byhmgard AB is removed (Cision)
|
|
|
On November 24, 2025, Byhmgard AB (the “Company”) received conditional approval for continued listing on NGM Nordic SME. NGM's listing decision was conditional, on among other things, on the Company holding an additional control meeting confirming that the equity had been restored.
An extraordinary general meeting was held in the Company on January 23, 2026. The presented liquidation balance sheet showed that the equity has been restored to at least the registered share capital.
With reference to the information above, Nordic Growth Market NGM AB has decided to remove the observation...
|
|
|
|
|
28.01.26 - 12:24
|
#26-09 Decision on delisting of Amnode AB from Nordic SME (Cision)
|
|
|
At the extraordinary general meeting on November 27, 2026, in Amnode AB (“the Company”) it was decided on a voluntary delisting. Due to this decision, the board has applied for delisting of the Company's shares.
NGM has now received and processed the application for delisting and decided that the last day of trading in the Company's shares will be on February 11, 2026.
With reference to the situation above, Nordic Growth Market NGM AB has decided to place the shares in the Company under observation with immediate effect. The observation status applies until further notice.
Information...
|
|
|
28.01.26 - 12:12
|
#26-08 Decision on delisting of Amnode AB from Nordic SME (Cision)
|
|
|
At the extraordinary general meeting on November 27, 2026, in Amnode AB (“the Company”) it was decided on a voluntary delisting. Due to this decision, the board has applied for delisting of the Company's shares.
NGM has now received and processed the application for delisting and decided that the last day of trading in the Company's shares will be on February 11, 2026.
With reference to the situation above, Nordic Growth Market NGM AB has decided to place the shares in the Company under observation with immediate effect. The observation status applies until further notice.
Information...
|
|
|
|
|
28.01.26 - 11:30
|
Skanska divests the office building Equilibrium 2 in Bucharest, Romania, for EUR 37M, about SEK 400M (Cision)
|
|
|
Skanska has divested the second phase of the Equilibrium office complex in Bucharest, Romania, for EUR 37M, about SEK 400M. The buyer is Magyar Posta Takarék Real Estate Investment Fund, managed by Gránit Asset Management. The transaction will be recorded by Skanska Commercial Development Europe in the first quarter of 2026. The transfer of the property is scheduled for the first quarter of 2026.
The second building, completed in the fourth quarter of 2022, offers approximately 20,000 square meters of premium leasable office space across eleven floors. It is distinguished by its forward-...
|
|
|
|
|
|
|
|
|
|
|
|